Adam Kaldor is an associate in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. His practice focuses on the life sciences industry, representing private and public companies of all stages in various intellectual property and commercial transactions.

Prior to joining the firm, Adam worked as a commercial counsel at a Fortune 100 company, acting primarily to provide legal advice and transactional support on intellectual property development and licensing deals, as well as marketing, distribution, and procurement matters.